SEC Form 4 · accession 0001437749-26-030597
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troy Edward Wilson
Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 9:13 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | S | 5,000 | $9.10 | D | 54,750 | D | |
| Common Stock | holding | — | — | — | 400 | I | By Child #1 | |
| Common Stock | holding | — | — | — | 150 | I | By Child #2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Adoption date of referenced 10b5-1(c) plan is: 06-15-2026